Video game aims to boost brain power in MS patients

NCT ID NCT04694534

Recruiting now Symptom relief Sponsor: Lille Catholic University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether playing a special online game for 20 minutes, four times a week, can improve memory and thinking speed in people with multiple sclerosis. Researchers will compare the game group to a control group receiving standard care. The trial aims to enroll 150 adults with relapsing-remitting or progressive MS who have cognitive complaints.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: serious game (online cognitive training program)
What this could lead to: If it works, this could offer a fun, accessible way to help people with multiple sclerosis sharpen their memory and thinking speed.
What could go wrong: This is an early-stage trial with no phase, so results are uncertain. The game may not provide lasting benefits beyond standard care, and improvements might be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEARNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

learning disability multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEARNING MEMORY MULTIPLE SCLEROSIS

Contacts and locations

Locations

CH Arras
RECRUITING

Arras, Hauts-de-France, 62000, France
CH LENS
RECRUITING

Lens, Hauts-de-France, 62300, France
CHRU
RECRUITING

Lille, Hauts-de-France, 59000, France
Charles Nicolle Hospital
RECRUITING

Rouen, Normandy, 76000, France
Saint Vincent hospital
RECRUITING

Lille, Hauts-de-France, 59000, France
Saint-Philibert hospital
RECRUITING

Lomme, Nord, 59462, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.